The 2013 Import and Export Market for Glycosides, Glands or Other Organs and Extracts, Antisera, Vaccines, and Similar Products in Bulgaria

On the demand side, exporters and strategic planners focusing on glycosides, glands or other organs and extracts, antisera, vaccines, and similar products in Bulgaria face a number of questions. Which countries are supplying glycosides, glands or other organs and extracts, antisera, vaccines, and similar products to Bulgaria? How important is Bulgaria compared to others in terms of the entire global and regional market? How much do the imports of glycosides, glands or other organs and extracts, antisera, vaccines, and similar products vary from one country of origin to another in Bulgaria? On the supply side, Bulgaria also exports glycosides, glands or other organs and extracts, antisera, vaccines, and similar products. Which countries receive the most exports from Bulgaria? How are these exports concentrated across buyers? What is the value of these exports and which countries are the largest buyers? This report was created for strategic planners, international marketing executives and import/export managers who are concerned with the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products in Bulgaria. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics which appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for glycosides, glands or other organs and extracts, antisera, vaccines, and similar products for those countries serving Bulgaria via exports, or supplying from Bulgaria via imports. It does so for the current year based on a variety of key historical indicators and econometric models. In what follows, Chapter 2 begins by summarizing where Bulgaria fits into the world market for imported and exported glycosides, glands or other organs and extracts, antisera, vaccines, and similar products. The